1. Home
  2. NEO vs PRA Comparison

NEO vs PRA Comparison

Compare NEO & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • PRA
  • Stock Information
  • Founded
  • NEO 2001
  • PRA 1976
  • Country
  • NEO United States
  • PRA United States
  • Employees
  • NEO N/A
  • PRA N/A
  • Industry
  • NEO Precision Instruments
  • PRA Property-Casualty Insurers
  • Sector
  • NEO Health Care
  • PRA Finance
  • Exchange
  • NEO Nasdaq
  • PRA Nasdaq
  • Market Cap
  • NEO 1.1B
  • PRA 1.2B
  • IPO Year
  • NEO 1999
  • PRA N/A
  • Fundamental
  • Price
  • NEO $9.15
  • PRA $24.11
  • Analyst Decision
  • NEO Buy
  • PRA Hold
  • Analyst Count
  • NEO 10
  • PRA 4
  • Target Price
  • NEO $12.56
  • PRA $21.00
  • AVG Volume (30 Days)
  • NEO 3.0M
  • PRA 377.4K
  • Earning Date
  • NEO 10-28-2025
  • PRA 11-06-2025
  • Dividend Yield
  • NEO N/A
  • PRA N/A
  • EPS Growth
  • NEO N/A
  • PRA N/A
  • EPS
  • NEO N/A
  • PRA 0.95
  • Revenue
  • NEO $689,189,000.00
  • PRA $1,128,928,000.00
  • Revenue This Year
  • NEO $10.40
  • PRA N/A
  • Revenue Next Year
  • NEO $10.11
  • PRA N/A
  • P/E Ratio
  • NEO N/A
  • PRA $25.43
  • Revenue Growth
  • NEO 9.70
  • PRA N/A
  • 52 Week Low
  • NEO $4.72
  • PRA $13.00
  • 52 Week High
  • NEO $19.12
  • PRA $24.22
  • Technical
  • Relative Strength Index (RSI)
  • NEO 67.00
  • PRA 69.66
  • Support Level
  • NEO $7.56
  • PRA $24.08
  • Resistance Level
  • NEO $9.24
  • PRA $24.22
  • Average True Range (ATR)
  • NEO 0.36
  • PRA 0.08
  • MACD
  • NEO 0.06
  • PRA 0.02
  • Stochastic Oscillator
  • NEO 92.86
  • PRA 76.34

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About PRA ProAssurance Corporation

ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.

Share on Social Networks: